GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GliaCure Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11195
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GliaCure Inc (GliaCure) is a developer of novel therapies for neurological and neuropsychiatric disorders. The company uses glia as an untapped resource for drug discovery, which controls the brain function in health and disease. It develops small molecule pharmaceuticals for the treatment of Alzheimer’s disease. GliaCure offers glia-targeted medicines to treat other disorders that include traumatic brain injury, down syndrome, parkinson’s disease, glioblastoma, neuropathic pain, epilepsy, psychiatric and sleep disorders. The company builds its existing discoveries on the role of astrocytes as a critical conduit for mediating fast-acting antidepressive effects. GliaCure is headquartered in Boston, Massachusetts, the US.

GliaCure Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GliaCure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GliaCure Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
GliaCure Raises USD1.6 Million in Venture Financing 10
GliaCure Raises USD5.8 Million in Series B Financing 11
GliaCure Raises USD3 Million in Venture Financing 12
Gliacure Raises Additional US$1.8 Million In Venture Financing 13
Licensing Agreements 14
GliaCure Enters into Licensing Agreement with Tufts University 14
GliaCure Inc – Key Competitors 15
GliaCure Inc – Key Employees 16
GliaCure Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
GliaCure Inc, Pharmaceuticals & Healthcare, Key Facts 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Deals By Therapy Area, 2012 to YTD 2018 8
GliaCure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GliaCure Raises USD1.6 Million in Venture Financing 10
GliaCure Raises USD5.8 Million in Series B Financing 11
GliaCure Raises USD3 Million in Venture Financing 12
Gliacure Raises Additional US$1.8 Million In Venture Financing 13
GliaCure Enters into Licensing Agreement with Tufts University 14
GliaCure Inc, Key Competitors 15
GliaCure Inc, Key Employees 16

List of Figures
GliaCure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Juwi Inc:電力:M&Aディール及び事業提携情報
    Summary Juwi Inc (Juwi), a subsidiary of juwi AG is a renewable energy company that operates wind and solar projects. The company’s services include development and acquisition, engineering, procurement, construction and operations and maintenance. Juwi's operations and maintenance services comprise …
  • Inovalon Holdings Inc (INOV):企業の財務・戦略的SWOT分析
    Summary Inovalon Holdings Inc (Inovalon), formerly MedAssurant Inc is a technology company that provides cloud-based platforms for healthcare industry. The company designs, develops and distributes software tools to provide healthcare and financial improvement solutions. It provides data driven solu …
  • Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • The Nisshin OilliO Group Ltd (2602):企業の財務・戦略的SWOT分析
    The Nisshin OilliO Group Ltd (2602) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Wipro Ltd:企業のM&A・事業提携・投資動向
    Wipro Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wipro Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Siemens AG (SIE):石油・ガス:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • China Airlines Ltd.:企業の戦略・SWOT・財務情報
    China Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TransAlta Corp:企業の発電所・SWOT分析2018
    TransAlta Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • M. Dias Branco SA Ind Com de Alimentos:企業の戦略・SWOT・財務情報
    M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report Summary M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Bin Qasim Ltd (FFBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Matinas BioPharma Holdings Inc (MTNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform to deliver various molecules such as small m …
  • Canadian Utilities Ltd (CU):電力:M&Aディール及び事業提携情報
    Summary Canadian Utilities Ltd (CUL), an ATCO company, is an electric utility. The company carries out electricity and natural gas distribution and transmission operations. It constructs and maintains electrical transmission and distribution lines and has stakes in generating plants through subsidia …
  • Beijing Enterprises Holdings Ltd:企業の戦略・SWOT・財務情報
    Beijing Enterprises Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Beijing Enterprises Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Canpotex Ltd:企業の戦略的SWOT分析
    Canpotex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Petronas Dagangan Bhd (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • Zimmer Biomet Holdings Inc.:企業のM&A・事業提携・投資動向
    Zimmer Biomet Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zimmer Biomet Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Oil and Natural Gas Corporation Ltd (ONGC)-石油・ガス分野:企業M&A・提携分析
    Summary Oil and Natural Gas Corporation Ltd (ONGC) is an integrated oil and gas company. It explores for and produces oil and natural gas; refines crude oil; and markets and distributes petroleum products. The company's product portfolio includes crude oil, natural gas, liquefied natural gas, naphth …
  • Murata Manufacturing Co Ltd (6981)-医療機器分野:企業M&A・提携分析
    Summary Murata Manufacturing Co., Ltd. (Murata) is an electronic component manufacturing company that carries out design, manufacture, and supply of advanced electronic materials, components, and multi-functional, high-density modules. Murata commercializes both finished and semi-finished goods. Its …
  • Greatship (India) Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Greatship (India) Ltd (GIL), a subsidiary of The Great Eastern Shipping Co. Ltd is an offshore oilfield service provider that offers shipping and transportation services. The company transports crude oil, petroleum products, gas and bulk commodities. It provides offshore logistics and drilli …
  • QRxPharma Ltd:企業の戦略的SWOT分析
    QRxPharma Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆